Published in Transplantation on August 01, 2016
The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies. J Immunol Res (2016) 0.75
Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med (2011) 6.72
Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science (2005) 6.48
Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med (2013) 6.31
Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med (2007) 5.31
Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol (2010) 2.66
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet (2005) 2.02
Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation (2008) 1.92
Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information. Am J Transplant (2015) 1.72
Prospective iterative trial of proteasome inhibitor-based desensitization. Am J Transplant (2015) 1.72
Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant (2007) 1.60
Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. J Am Soc Nephrol (2014) 1.60
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Determinants of C1q binding in the single antigen bead assay. Transplantation (2014) 1.51
Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation. Transplantation (2014) 1.45
Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol (2011) 1.40
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant (2005) 1.32
The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol (2012) 1.29
Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant (2008) 1.27
Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol (2009) 1.19
Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant (2012) 1.18
The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Transplantation (2013) 1.11
HLA antibody specification using single-antigen beads--a technical solution for the prozone effect. Transplantation (2011) 1.11
Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation. Liver Transpl (2012) 1.10
Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl Immunol (2011) 1.07
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. J Am Soc Nephrol (2015) 1.07
Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol (2006) 1.05
Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant (2012) 1.04
Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? Hum Immunol (2011) 1.01
Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation. Hum Immunol (2009) 1.00
Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays. Transplantation (2014) 0.99
The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96
Solid phase HLA antibody detection technology--challenges in interpretation. Tissue Antigens (2010) 0.95
Complement-binding anti-HLA antibodies and kidney transplantation. N Engl J Med (2014) 0.95
Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med (1979) 0.94
Utility of HLA Antibody Testing in Kidney Transplantation. J Am Soc Nephrol (2015) 0.93
The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation (1999) 0.92
Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation (2003) 0.92
Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion. Transfus Med Hemother (2013) 0.92
HLA antibody detection with solid phase assays: great expectations or expectations too great? Am J Transplant (2014) 0.92
Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation. Transplantation (2001) 0.91
Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol (2011) 0.91
Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation (2011) 0.89
Endothelial cell antibodies associated with novel targets and increased rejection. J Am Soc Nephrol (2014) 0.89
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation. Am J Transplant (2013) 0.89
Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes. Am J Transplant (2013) 0.85
Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant (2009) 0.85
Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients. Transplantation (2014) 0.85
Impact of donor-specific antibodies on results of liver transplantation. Curr Opin Organ Transplant (2013) 0.85
Endothelial cells as targets of allograft rejection. Transplantation (2006) 0.85
The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays. Transplantation (2007) 0.85
Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. Methods Mol Biol (2013) 0.84
Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies. Transplantation (2009) 0.84
Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens (2009) 0.83
Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl (2014) 0.83
Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay. Hum Immunol (2012) 0.83
Moving beyond HLA: a review of nHLA antibodies in organ transplantation. Hum Immunol (2013) 0.83
Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody. Transplantation (2012) 0.80
Impact of pronase on flow cytometric crossmatch outcome. Hum Immunol (2011) 0.79
Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion (2013) 0.79
The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation. Clin Exp Immunol (2013) 0.78
Interpretation of HLA single antigen bead assays. Transplant Rev (Orlando) (2013) 0.78
Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Transplantation (2015) 0.77
Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation. J Heart Lung Transplant (2014) 0.77
The significance of a donor-specific vessel crossmatch in renal transplantation. Transplantation (1988) 0.76
HLA Class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report. Transplant Proc (2007) 0.76
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis (2004) 3.11
Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation (2013) 2.10
Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol (2010) 2.09
The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med (2010) 2.06
Economic rewards for blood donation: validity of the donor questionnaire as litmus test. Clin Chem (2013) 1.99
Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation (2008) 1.92
Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol (2010) 1.91
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant (2003) 1.86
Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant (2005) 1.79
Chronic renal dysfunction late after liver transplantation. Liver Transpl (2002) 1.74
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int (2005) 1.73
Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation. Transplantation (2006) 1.69
Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int (2014) 1.52
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant (2011) 1.51
Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant (2005) 1.51
Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation (2009) 1.47
The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion (2010) 1.44
Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant (2005) 1.37
Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant (2003) 1.29
Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation (2004) 1.29
Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation (2008) 1.23
Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant (2005) 1.20
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood (2005) 1.18
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation (2005) 1.17
Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc (2011) 1.15
Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant (2003) 1.13
Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med (2014) 1.11
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol (2005) 1.11
Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant (2004) 1.10
Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes (2011) 1.09
Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int (2003) 1.08
Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl Immunol (2011) 1.07
Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant (2006) 1.06
Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant (2008) 1.05
ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation (2003) 1.04
Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant (2004) 1.01
Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation (2010) 0.99
In vivo inactivation of MASTL kinase results in thrombocytopenia. Exp Hematol (2009) 0.98
Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation (2004) 0.98
A meta-analysis of kidney microarray datasets: investigation of cytokine gene detection and correlation with rt-PCR and detection thresholds. BMC Genomics (2007) 0.98
The development of kidney allocation policy. Am J Kidney Dis (2005) 0.96
X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP). Exp Hematol (2003) 0.96
Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation (2007) 0.96
Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood (2005) 0.95
Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation (2002) 0.94
Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol (2010) 0.94
Improving the prediction of donor kidney quality: deceased donor score and resistive indices. Transplantation (2005) 0.93
Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. Transplantation (2007) 0.91
Significance and implications of capillaritis during acute rejection of kidney allografts. Transplantation (2010) 0.90
Pancreas transplants: experience with 232 percutaneous US-guided biopsy procedures in 88 patients. Radiology (2004) 0.89
Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys. J Am Coll Surg (2013) 0.87
Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation (2004) 0.87
A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation (2005) 0.87
Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function. Transplantation (2012) 0.87
Clinical Trials for Immunosuppression in Transplantation; The Case for Reform and Change in Direction. Transplantation (2017) 0.87
United Network for Organ Sharing's expanded criteria donors: is stratification useful? Clin Transplant (2005) 0.86
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. Transplantation (2008) 0.85
Preemptive living donor kidney transplantation: do the benefits extend to all recipients? Transplantation (2007) 0.85
Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant (2009) 0.85
The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays. Transplantation (2007) 0.85
Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int (2004) 0.84
Human leukocyte antigen genetics and clinical features of self-treated patients on a gluten-free diet. J Clin Gastroenterol (2013) 0.84
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. Transplantation (2004) 0.83
ABO incompatible kidney transplantation. Curr Opin Nephrol Hypertens (2007) 0.83
Decline in native renal function early after bladder-drained pancreas transplantation alone. Transplantation (2004) 0.83
Can a transplanted living donor kidney function equivalently to its native partner? Am J Transplant (2002) 0.83
Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl (2014) 0.83
Reassessing Preemptive Kidney Transplantation in the United States: Are We Making Progress? Transplantation (2016) 0.82
Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation (2013) 0.82
Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens. Transplantation (2005) 0.82
The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo. Transplantation (2011) 0.82
Assessing the efficacy of kidney paired donation--performance of an integrated three-site program. Transplantation (2014) 0.81
Compensatory hypertrophy of the remaining kidney in medically complex living kidney donors over the long term. Transplantation (2015) 0.80
Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation (2004) 0.80
Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors. Transplantation (2013) 0.80
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation. Am J Nephrol (2012) 0.80
Forskolin suppresses insulin gene transcription in islet beta-cells through a protein kinase A-independent pathway. Cell Signal (2003) 0.79
Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejection. J Am Soc Hypertens (2011) 0.79
Conquering absolute contraindications to transplantation: positive-crossmatch and ABO-incompatible kidney transplantation. Surgery (2005) 0.79
Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index. J Am Soc Nephrol (2007) 0.79
Intravitreal Antivascular Endothelial Growth Factor Therapy May Induce Proteinuria and Antibody Mediated Injury in Renal Allografts. Transplantation (2015) 0.78
Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant (2005) 0.78
Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery (2002) 0.78
Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Am J Transplant (2003) 0.77
The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts. Transpl Immunol (2012) 0.77
A novel model of allograft rejection: immune reconstitution of Rag-1 recipients with 2C transgenic T-cell receptor lymphocytes. Transpl Int (2005) 0.77
Immunomodulation through inhibition of multiple adhesion molecules generates resistance to autoimmune diabetes in NOD mice. J Autoimmun (2004) 0.77
Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation. Transplantation (2014) 0.77
Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Transplantation (2007) 0.76
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation (2013) 0.76
32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody. Transplantation (2016) 0.76
Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol (2010) 0.75
Should we be performing pancreas transplants? Am J Transplant (2004) 0.75
Survival Benefit in Older Patients Associated with Earlier Transplant with High KDPI Kidneys. Transplantation (2016) 0.75